Scientists in the UK and Germany discovered a new doorway that the COVID-19 virus uses to infect human cells. This reveals new therapeutic possibilities for blocking the virus.
Academic rigour, journalistic flair
Articles on SARS-CoV-2
Displaying 321 - 340 of 584 articles
Over the approaching holidays, people around the world will want to travel to see friends and family. Getting tested for the coronavirus can make this safer, but testing alone is not a perfect answer.
An optical sensor that can detect individual molecules promises early detection of diseases and environmental contamination.
Hand hygiene is a critical part of the response to COVID-19. Washing hands at regular intervals during the day is essential. If water and soap are unavailable, hand sanitisers are an alternative.
A previous version of Melbourne’s COVID roadmap flagged an exclusive bubble between two households. The new plan allows residents to have two adult visitors per day, which is far riskier.
Law enforcement is a blunt tool to achieve social conformity with COVID-safe rule. It’s time to start thinking about other strategies to promote new norms.
Scientists handle virus samples every day but infections are incredibly rare – here’s why.
A COVID-19 vaccine isn’t the only tool for fighting this pandemic. An immunologist argues that safe pneumonia vaccines would reduce the severity of COVID-19, save lives and prevent the worst cases.
As ready as you are to be done with COVID-19, it’s not going anywhere soon. A historian of disease describes how once a pathogen emerges, it’s usually here to stay.
A new study is the first to identify sex differences in inflammation and immune cell activation in response to SARS-CoV-2 infection, which causes COVID-19.
Patients suffering from severe COVID-19 may be experiencing a rogue antibody response similar to that seen in autoimmune diseases. The findings offer new approaches for COVID-19 therapy.
This isn’t the first time America’s schoolchildren have studied remotely – and Chicago’s 1937 ‘radio school’ experiment shows how technology can fill the gap during a crisis.
The president and first lady Melania Trump have both tested positive for the coronavirus. Here’s what the physicians and scientists know about the best treatments for the disease it causes.
Older coronavirus patients face grimmer outlooks. A virologist explains the aging-related changes in how immune systems work that are to blame.
The Trump administration wants to go it alone when it comes to vaccine development and distribution. What does this mean for the U.S. and the world?
Antibodies are great for neutralizing viruses. But they are big and bulky. Antibody engineers are now creating smaller synthetic antibody-like molecules that may be better for fighting COVID-19.
Children struggle amidst adversity, but these tumultuous and highly emotional times make it a critical time to teach ‘resilience’ – giving kids coping skills.
A new test, which can diagnose COVID-19 in 15 minutes, has been approved by the TGA. But it’s no silver bullet.
Several vaccines are in Phase 3 trials. So when will we know whether any of these will protect against COVID-19?
There’s a targeted subunit protein vaccine, an mRNA vaccine, and a needle-free DNA vaccine. Here’s what that all means.
Top contributors
-
Professor of Medicine, University of Virginia
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Associate Professor, Epidemiology, Deakin University
-
Research Leader in Virology and Infectious Disease, Griffith University
-
Instructor of Human Immunology, Emory University
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor, Nursing, School of Nursing and Midwifery, Griffith University
-
Postdoctoral Fellow in Virology, University of Colorado Boulder
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Scientific Officer, University of Leeds
-
Lecturer in Virology, Queen's University Belfast
-
Professor of Molecular, Cellular and Developmental Biology, University of Colorado Boulder
-
Postdoctoral Fellow in Virology and Immunology, University of Colorado Boulder
